# Evolus, Inc. (EOLS) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Evolus, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/EOLS/mda/fy2025/): filed 2026-03-03; accession 0001628280-26-014001 (https://www.sec.gov/Archives/edgar/data/1570562/000162828026014001/eols-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/EOLS/mda/fy2024/): filed 2025-03-04; accession 0001570562-25-000020 (https://www.sec.gov/Archives/edgar/data/1570562/000157056225000020/eols-20241231.htm)
- [FY 2023 MD&A](/company/EOLS/mda/fy2023/): filed 2024-03-07; accession 0001570562-24-000041 (https://www.sec.gov/Archives/edgar/data/1570562/000157056224000041/eols-20231231.htm)
- [FY 2022 MD&A](/company/EOLS/mda/fy2022/): filed 2023-03-08; accession 0001570562-23-000038 (https://www.sec.gov/Archives/edgar/data/1570562/000157056223000038/eols-20221231.htm)
- [FY 2021 MD&A](/company/EOLS/mda/fy2021/): filed 2022-03-03; accession 0001570562-22-000067 (https://www.sec.gov/Archives/edgar/data/1570562/000157056222000067/eols-20211231.htm)

Back to /company/EOLS/